REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 39 filers reported holding REDHILL BIOPHARMA LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $57,000 | -46.7% | 13,000 | -10.3% | 0.00% | -50.0% |
| Q3 2019 | $107,000 | +13.8% | 14,500 | 0.0% | 0.01% | +33.3% |
| Q2 2019 | $94,000 | -23.6% | 14,500 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $123,000 | -55.8% | 14,500 | -71.0% | 0.01% | -58.8% |
| Q4 2018 | $278,000 | -34.1% | 50,000 | +2.7% | 0.02% | -19.0% |
| Q3 2018 | $422,000 | +8.8% | 48,706 | +1.5% | 0.02% | +23.5% |
| Q2 2018 | $388,000 | +57.1% | 48,000 | 0.0% | 0.02% | +30.8% |
| Q1 2018 | $247,000 | +1.2% | 48,000 | 0.0% | 0.01% | -7.1% |
| Q4 2017 | $244,000 | – | 48,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 367,346 | $926,000 | 0.15% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,950,002 | $4,914,000 | 0.11% |
| Claret Asset Management Corp | 95,430 | $240,000 | 0.05% |
| Annandale Capital, LLC | 43,532 | $110,000 | 0.04% |
| ARK Investment Management | 861,798 | $2,172,000 | 0.01% |
| Virtu Financial LLC | 26,864 | $68,000 | 0.01% |
| Ancora Advisors LLC | 82,048 | $207,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 4,600 | $1,372,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 25,499 | $64,000 | 0.00% |
| ATTICUS WEALTH MANAGEMENT, LLC | 2,425 | $6,000 | 0.00% |